Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
H

Health In Tech Inc
NASDAQ:HIT

Watchlist Manager
Health In Tech Inc
NASDAQ:HIT
Watchlist
Price: 0.9151 USD -2.29% Market Closed
Market Cap: $60m
Write Note Create Alert Ask AI

Wall St Price Targets

HIT Price Targets Summary
Health In Tech Inc

Wall Street analysts forecast HIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIT is 3.774 USD with a low forecast of 3.03 USD and a high forecast of 4.305 USD.

HIT Lowest Forecast
Wall Street Target
$3.03
231% Upside
HIT Average Forecast
Wall Street Target
$3.774
312% Upside
HIT Highest Forecast
Wall Street Target
$4.305
370% Upside
Lowest Forecast
Price Target
3.03 USD
231% Upside
Average Forecast
Price Target
3.774 USD
312% Upside
Highest Forecast
Price Target
4.305 USD
370% Upside
Health In Tech Inc Competitors:
Price Targets
NNN
National Retail Properties Inc
12% Upside
AON
Aon PLC
34% Upside
UNF
UniFirst Corp
1% Upside
C
OU8
Centurion Corporation Ltd
29% Upside
NNN
National Retail Properties Inc
12% Upside
AON
Aon PLC
34% Upside
UNF
UniFirst Corp
1% Upside
C
OU8
Centurion Corporation Ltd
29% Upside

Revenue
Forecast

32% / Year
Past Growth
50% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
32% / Year
Past Growth
50% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 2 years is 50%.

What are analyst estimates?

Gross Profit
Forecast

11% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 2 years is 41%.

What are analyst estimates?

Operating Income
Forecast

-33% / Year
Past Growth
154% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-33% / Year
Past Growth
154% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been -33%. The projected CAGR for the next 2 years is 154%.

What are analyst estimates?

Pre-Tax Income
Forecast

-30% / Year
Past Growth
161% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-30% / Year
Past Growth
161% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been -30%. The projected CAGR for the next 2 years is 161%.

What are analyst estimates?

Net Income
Forecast

-28% / Year
Past Growth
171% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-28% / Year
Past Growth
171% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been -28%. The projected CAGR for the next 2 years is 171%.

What are analyst estimates?

Continue HIT Research

Summary
HIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
HIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HIT stock valuation using valuation multiples.
Wall St Estimates
HIT price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HIT's stock price target?
Price Target
3.774 USD

According to Wall Street analysts, the average 1-year price target for HIT is 3.774 USD with a low forecast of 3.03 USD and a high forecast of 4.305 USD.

What is the Revenue forecast for Health In Tech Inc?
Projected CAGR
50%

Over the last 2 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 2 years is 50%.

What is the Gross Profit forecast for Health In Tech Inc?
Projected CAGR
41%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 2 years is 41%.

What is the Operating Income forecast for Health In Tech Inc?
Projected CAGR
154%

Over the last 2 years, the compound annual growth rate for Operating Income has been -33%. The projected CAGR for the next 2 years is 154%.

What is the Pre-Tax Income forecast for Health In Tech Inc?
Projected CAGR
161%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been -30%. The projected CAGR for the next 2 years is 161%.

What is the Net Income forecast for Health In Tech Inc?
Projected CAGR
171%

Over the last 2 years, the compound annual growth rate for Net Income has been -28%. The projected CAGR for the next 2 years is 171%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett